Previous Next

2024-02-12

Factor VIII and Von Willebrand factor

Hematology

Coagulation factor VIII and Von Willebrand factor are essential for coagulation and platelet aggregation. In a meta-analysis including data from 45,289 patients, researchers here identified genetic associations between circulating levels of these two factors. They studied three genes causally involved in the release of factor VIII from human liver endothelial cells and Von Willebrand factor from human umbilical vein endothelial cells. Using whole-genome sequencing analyses, the researchers identified new loci involved in the release of these two coagulation factors. They also assessed their impact on the risk of thrombotic events.

Source(s) :
Paul S de Vries et al. A genetic association study of circulating coagulation Factor VIII and von Willebrand Factor levels. Blood. 2024 Feb 6:blood.2023021452. ;

Last press reviews


The real role of diet after prostate cancer: what does the evidence show?

By Lila Rouland | Published on November 6, 2025 | 3 min read<br>

Prostate cancer and diet: which eating pattern helps with prevention?

By Lila Rouland | Published on November 6, 2025 | 3 min read<br>&...

Curcumin in prostate cancer: a promising therapy supported by nanotechnology

By Carolina Lima | Published on November 4, 2025 | 3 min read<br>